TLX CIK: 2007191

Telix Pharmaceuticals Ltd

  • Australia
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25

Assets

(positive)
Change from FY23 to FY25
billions USD
FY23:
0.16
FY24:
0.57
FY25:
0.33
(positive)
Change from FY23 to FY25
billions USD
FY23:
0.12
FY24:
0.37
FY25:
0.83
Total assets
Change from FY23 to FY25
billions USD
FY23:
0.28
FY24:
0.94
FY25:
1.16

Liabilities & Equity

(negative)
Change from FY23 to FY25
billions USD
FY23:
0.11
FY24:
0.21
FY25:
0.23
(negative)
Change from FY23 to FY25
billions USD
FY23:
0.06
FY24:
0.38
FY25:
0.52
(positive)
Change from FY23 to FY25
billions USD
FY23:
0.10
FY24:
0.35
FY25:
0.42
Total liabilities & equity
Change from FY23 to FY25
billions USD
FY23:
0.28
FY24:
0.94
FY25:
1.16

All amounts in billions USD Data source:SEC EDGAR